Stealth BioTherapeutics Corp (MITO):企業の財務・戦略的SWOT分析

◆英語タイトル:Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2353343FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Stealth BioTherapeutics Corp (MITO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Stealth BioTherapeutics Corp (Stealth BioTherapeutics), formerly Stealth Peptides International Inc, a subsidiary of Morningside Venture Investments Ltd, is an early stage biotechnology company. It discovers, develops, and commercializes novel therapies for diseases and disorders associated with mitochondrial dysfunction. The company is investigating elamipretide, a peptide compound that penetrates into cell membranes, for the treatment of primary mitochondrial myopathy, barth syndrome, leber’s hereditary optic neuropathy, and dry age-related macular degeneration. Stealth BioTherapeutics is also evaluating SBT-20 for the treatment of neurodegenerative diseases related to mitochondrial dysfunction; and SBT-272, a pre-clinical candidate, for the treatment of rare neurodegenerative diseases. Stealth BioTherapeutics is headquartered in Grand Cayman, Cayman Islands.

Stealth BioTherapeutics Corp Key Recent Developments

Dec 07,2020: Stealth BioTherapeutics announces appointment of Eve E. Slater, M.D., F.A.C.C. to its board of directors
Nov 05,2020: Stealth BioTherapeutics reports third quarter 2020 financial results and recent business highlights
Aug 06,2020: Stealth BioTherapeutics reports second quarter 2020 financial results and recent business highlights
May 07,2020: Stealth BioTherapeutics reports first quarter 2020 financial results and recent business highlights
Apr 01,2020: Stealth BioTherapeutics reports fiscal year 2019 financial results and recent business highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Stealth BioTherapeutics Corp – Key Facts
Stealth BioTherapeutics Corp – Key Employees
Stealth BioTherapeutics Corp – Key Employee Biographies
Stealth BioTherapeutics Corp – Major Products and Services
Stealth BioTherapeutics Corp – History
Stealth BioTherapeutics Corp – Company Statement
Stealth BioTherapeutics Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Stealth BioTherapeutics Corp – Business Description
Stealth BioTherapeutics Corp – Corporate Strategy
Stealth BioTherapeutics Corp – SWOT Analysis
SWOT Analysis – Overview
Stealth BioTherapeutics Corp – Strengths
Stealth BioTherapeutics Corp – Weaknesses
Stealth BioTherapeutics Corp – Opportunities
Stealth BioTherapeutics Corp – Threats
Stealth BioTherapeutics Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Stealth BioTherapeutics Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 07, 2020: Stealth BioTherapeutics announces appointment of Eve E. Slater, M.D., F.A.C.C. to its board of directors
Nov 05, 2020: Stealth BioTherapeutics reports third quarter 2020 financial results and recent business highlights
Aug 06, 2020: Stealth BioTherapeutics reports second quarter 2020 financial results and recent business highlights
May 07, 2020: Stealth BioTherapeutics reports first quarter 2020 financial results and recent business highlights
Apr 01, 2020: Stealth BioTherapeutics reports fiscal year 2019 financial results and recent business highlights
Nov 14, 2019: Stealth BioTherapeutics reports third quarter 2019 financial results and recent business highlights
Oct 11, 2019: Alexion, Stealth to develop elamipretide for mitochondrial diseases
Sep 03, 2019: Stealth BioTherapeutics announces appointment of Robert Weiskopf as Chief Financial Officer
Aug 14, 2019: Stealth BioTherapeutics reports first half 2019 financial results and recent business highlights
May 15, 2019: Stealth BioTherapeutics reports first quarter 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Stealth BioTherapeutics Corp, Key Facts
Stealth BioTherapeutics Corp, Key Employees
Stealth BioTherapeutics Corp, Key Employee Biographies
Stealth BioTherapeutics Corp, Major Products and Services
Stealth BioTherapeutics Corp, History
Stealth BioTherapeutics Corp, Subsidiaries
Stealth BioTherapeutics Corp, Key Competitors
Stealth BioTherapeutics Corp, Ratios based on current share price
Stealth BioTherapeutics Corp, Annual Ratios
Stealth BioTherapeutics Corp, Annual Ratios (Cont...1)
Stealth BioTherapeutics Corp, Interim Ratios
Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Stealth BioTherapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Stealth BioTherapeutics Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Stealth BioTherapeutics Corp (MITO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FANUC CORPORATION:企業の戦略・SWOT・財務情報
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SNC-Lavalin Group Inc.:企業のM&A・事業提携・投資動向
    SNC-Lavalin Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SNC-Lavalin Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Nordea Bank AB:企業のM&A・事業提携・投資動向
    Nordea Bank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordea Bank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Grupo Grana y Montero SAA (GRAMONC1):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupo Grana y Montero SAA (Grana y Montero) is a group company that provides engineering and infrastructure services. The company’s business areas include engineering and construction, infrastructure development, real estate and technical services. It provides engineering procurement and con …
  • Sermsuk Public Company Limited:企業の戦略・SWOT・財務分析
    Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Subaru Corp:企業の戦略・SWOT・財務分析
    Subaru Corp - Strategy, SWOT and Corporate Finance Report Summary Subaru Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • The York Water Co (YORW):企業の財務・戦略的SWOT分析
    The York Water Co (YORW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務情報
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Galenica Ltd:企業の戦略・SWOT・財務情報
    Galenica Ltd - Strategy, SWOT and Corporate Finance Report Summary Galenica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CenturyLink, Inc.:企業の戦略・SWOT・財務情報
    CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report Summary CenturyLink, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company. It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnosti …
  • Burgan Bank Sak
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Eneva SA (ENEV3):電力:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Kingboard Laminates Holdings Limited (1888):企業の財務・戦略的SWOT分析
    Kingboard Laminates Holdings Limited (1888) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆